The history of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in revenue , its patent expiration created a wave of generic competition , significantly eroding its position . While specific firms may seek to capitalize on male sexual dysfunction, the present